Amylyx Pharmaceuticals
Amylyx Pharmaceuticals is a biopharmaceutical company best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.

Year Established: 2013
Stock Ticker: AMLX
Exchange: NASDAQ
Amylyx Pharmaceuticals is a biopharmaceutical company best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.
Amylyx Pharmaceuticals is a biopharmaceutical company best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.
Amylyx Pharmaceuticals is a biopharmaceutical company best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.